Investors

Building the platform that evolves microbes.

Selva Nexus is a founder-led biotech. Our proprietary autoselection technology automates microbial evolution — across therapeutic, industrial, and defense applications. We’re in active conversations with select investors aligned with the bioeconomy thesis.

Investor inquiries.

If you’d like to learn more about our platform, traction, or upcoming raise — get in touch.